Litigation Details for Hospira Inc. v. Eurohealth International Sarl (D. Del. 2014)
✉ Email this page to a colleague
Hospira Inc. v. Eurohealth International Sarl (D. Del. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-04-18 |
| Court | District Court, D. Delaware | Date Terminated | 2016-06-03 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Parties | EUROHEALTH INTERNATIONAL SARL | ||
| Patents | 6,716,867; 8,222,015 | ||
| Attorneys | Erin E. McLeod | ||
| Firms | Law Office of Michael R. Abram | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Hospira Inc. v. Eurohealth International Sarl
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Biologic Drugs cited in Hospira Inc. v. Eurohealth International Sarl
The biologic drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Hospira Inc. v. Eurohealth International Sarl (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-01-14 | 105 | Friedman, M.D., on Infringement of U.S. Patent No. 6,716,867; and (iii) the Opening Expert Report of … 2014 3 June 2016 1:14-cv-00487 830 Patent None District Court, D. Delaware | External link to document | |
| 2016-02-16 | 112 | Michael A.E. Ramsay, M.D. on Validity of U.S. Patent No. 6,716,867; and (ii) the Second Expert Report of Mohan… 2014 3 June 2016 1:14-cv-00487 830 Patent None District Court, D. Delaware | External link to document | |
| 2016-03-08 | 115 | Friedman, M.D., on Infringement of U.S. Patent No. 6,716,867; (ii) the Reply Expert Report of Charles… 2014 3 June 2016 1:14-cv-00487 830 Patent None District Court, D. Delaware | External link to document | |
| 2016-05-02 | 119 | action for alleged patent infringement of U.S. Patent No. 6,716,867 (the “’867 patent”), arising under …under the patent laws and the Hatch-Waxman Act. See 35 U.S.C. §§ 1 et seq.; 21 U.S.C. § 355. The jurisdiction…following claim terms in connection with the ’867 patent: (i) “intensive care unit,” (ii) “sedating a patient… 2014 3 June 2016 1:14-cv-00487 830 Patent None District Court, D. Delaware | External link to document | |
| 2016-06-03 | 129 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,716,867. (asw) (Entered: 06… 2014 3 June 2016 1:14-cv-00487 830 Patent None District Court, D. Delaware | External link to document | |
| 2015-08-21 | 60 | Hospira asserts one patent in this litigation: U.S. Patent No. 6,716,867 (“the ’867 patent”’) (attached as… This is not the first venue in which the ’867 patent has been adjudicated. In May 2012, following a…holding in relevant part that the claims of the ’867 patent are invalid as obvious.1 Hospira appealed, but…Hospira free to assert the previously-invalidated patent against additional parties, including Eurohealth…terms in an apparent effort to distance the ’867 patent claims from the invalidating prior art relied | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
